COVID-19: 15 pharmaceutical companies working on different drugs, vaccines – expert



“15 pharmaceutical companies, including JOHNSON and JOHNSON, as well as PFIZER and SANOFI, are already working on different drugs and vaccines which are at different stages of clinical trials.”

Dr Arun Balaganga, Medical Director, Indian International Healthcare Centre, Abuja, who disclosed this today, says there is likely to be a breakthrough in the search for a drug or vaccine for COVID-19, latest by June.

Balaganga, an Indian doctor resident in Abuja, said: ” China and India are already using hydroxychloroquine to treat patients of the virus.

“Right now, there are no vaccine trials in India to the best of my knowledge, but there are lists of 12 to 15 companies working on different combinations.

“Nobody likes to live in a compromised situation; everybody is doing the best, but if some kind of drug trials is successful, then, probably in one or two months time, we will be in a position to contain the virus if we have the proper drugs.

“Some of the drugs can be ready in two months because they are in the phase three of the clinical trials so those drugs can be ready.

“Pharmaceutical company GILEAD is working on a drug called REMDESIVIR that is in clinical phase trial three, then ABABY is working on LOPINAVIR- RITONAVIR combination (second line HIV drug), and it’s also in phase three of the clinical trial.

“So, basically, if they are proving effective, then there is actually hoped for all of us. Vaccination trial has already started in different parts of the world”

He explained that every country had its own system of approval not subjected to the World Health Organisation (WHO).

Source: Guardian Nigeria

Leave a Reply